40V

SGX

iX Biopharma Ltd

Health CareSingapore

Overview Financials Dividends(soon)Directors Ownership(soon)

Board of Directors

2 current members

Heng Fai Chan

Executive Chair (Chair)

Healthcare & Life SciencesStrategy & Leadership

Sheng Hon Lim

Senior VP of Business Development, Investor Relations Officer & Executive Director

Business DevelopmentInvestor RelationsHealthcare & Life SciencesCorporate Governance

Executive Management

5 current executives

Tung Moe Chan BApSc, MBA, MEng

CEO

Healthcare & Life SciencesEngineeringStrategy & Leadership

Wai Leung Lui

CFO

Finance & AccountingHealthcare & Life Sciences

Kan Fai Lum

CTO

Technology LeadershipDigital TransformationHealthcare & Life Sciences

Ang Hay Kim

Senior Vice President of Corporate Affairs

Corporate AffairsHealthcare & Life SciencesCorporate Governance

Jong Yuh Gn L.L.B., LL.B. (Hons)

Company Secretary

Corporate GovernanceLegal & Compliance

Price Chart

Insufficient price data

Key Metrics

P/E Ratio-

P/B Ratio1.22

EV/EBITDA-1.64

Dividend Yield-

ROE-25.1%

ROA-15.2%

Net Margin0.0%

Debt/Equity0.01

Net Debt/EBITDA-

FCF Yield-

Governance Score

SGX Code of Corporate Governance

StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.

Data sources · Full disclaimer